DOCSLIB.ORG

Mouse Hnrnpa3 Knockout Project (CRISPR/Cas9)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mouse Hnrnpa3 Knockout Project (CRISPR/Cas9) https://www.alphaknockout.com Mouse Hnrnpa3 Knockout Project (CRISPR/Cas9) Objective: To create a Hnrnpa3 knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Hnrnpa3 gene (NCBI Reference Sequence: NM_146130 ; Ensembl: ENSMUSG00000059005 ) is located on Mouse chromosome 2. 11 exons are identified, with the ATG start codon in exon 1 and the TAA stop codon in exon 10 (Transcript: ENSMUST00000111964). Exon 2~8 will be selected as target site. Cas9 and gRNA will be co-injected into fertilized eggs for KO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Exon 2 starts from about 6.42% of the coding region. Exon 2~8 covers 78.45% of the coding region. The size of effective KO region: ~2249 bp. The KO region does not have any other known gene. Page 1 of 9 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele 5' gRNA region gRNA region 3' 1 2 3 4 5 6 7 8 11 Legends Exon of mouse Hnrnpa3 Knockout region Page 2 of 9 https://www.alphaknockout.com Overview of the Dot Plot (up) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section upstream of Exon 2 is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Overview of the Dot Plot (down) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 1313 bp section downstream of Exon 8 is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Page 3 of 9 https://www.alphaknockout.com Overview of the GC Content Distribution (up) Window size: 300 bp Sequence 12 Summary: Full Length(2000bp) | A(22.5% 450) | C(20.65% 413) | T(28.55% 571) | G(28.3% 566) Note: The 2000 bp section upstream of Exon 2 is analyzed to determine the GC content. Significant high GC-content regions are found. The gRNA site is selected outside of these high GC-content regions. Overview of the GC Content Distribution (down) Window size: 300 bp Sequence 12 Summary: Full Length(1313bp) | A(30.46% 400) | C(16.53% 217) | T(33.89% 445) | G(19.12% 251) Note: The 1313 bp section downstream of Exon 8 is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Page 4 of 9 https://www.alphaknockout.com BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 2000 1 2000 2000 100.0% chr2 + 75659467 75661466 2000 browser details YourSeq 33 1247 1292 2000 94.5% chr1 - 105910030 105910260 231 browser details YourSeq 31 1290 1359 2000 94.2% chr8 + 107276036 107276105 70 browser details YourSeq 31 1291 1363 2000 97.0% chr10 + 12110920 12110994 75 browser details YourSeq 26 1332 1359 2000 96.5% chr17 - 46224439 46224466 28 browser details YourSeq 26 1302 1359 2000 72.5% chr19 + 4730876 4730933 58 browser details YourSeq 25 1326 1355 2000 93.2% chr5 + 86509145 86509176 32 browser details YourSeq 24 1314 1337 2000 100.0% chr11 + 77212288 77212311 24 browser details YourSeq 22 869 890 2000 100.0% chr6 - 139555896 139555917 22 browser details YourSeq 21 1558 1578 2000 100.0% chr9 + 39281366 39281386 21 browser details YourSeq 21 1809 1829 2000 100.0% chr14 + 40895586 40895606 21 browser details YourSeq 20 1317 1336 2000 100.0% chr1 - 119723172 119723191 20 browser details YourSeq 20 285 304 2000 100.0% chr1 - 64533451 64533470 20 browser details YourSeq 20 776 795 2000 100.0% chr1 + 44984590 44984609 20 Note: The 2000 bp section upstream of Exon 2 is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 1313 1 1313 1313 100.0% chr2 + 75663716 75665028 1313 browser details YourSeq 105 310 477 1313 93.6% chr14 - 20352253 20352446 194 browser details YourSeq 95 357 484 1313 95.4% chr1 + 12818929 13178437 359509 browser details YourSeq 94 314 480 1313 90.6% chr17 - 62050923 62051110 188 browser details YourSeq 92 357 478 1313 95.2% chr5 - 66267227 66267373 147 browser details YourSeq 89 362 482 1313 92.5% chr8 - 110800444 110800579 136 browser details YourSeq 86 315 483 1313 92.3% chr7 - 80378153 80378338 186 browser details YourSeq 86 363 480 1313 91.4% chr15 - 40117186 40117326 141 browser details YourSeq 85 369 477 1313 93.0% chr8 + 123843937 123844066 130 browser details YourSeq 85 305 450 1313 94.0% chr4 + 119159600 119159750 151 browser details YourSeq 84 362 477 1313 94.7% chr15 + 12159334 12159449 116 browser details YourSeq 82 315 450 1313 91.2% chr5 + 99095704 99095839 136 browser details YourSeq 81 362 477 1313 94.6% chr2 - 166061527 166061665 139 browser details YourSeq 80 312 453 1313 92.8% chr19 - 10223921 10224063 143 browser details YourSeq 80 363 473 1313 91.8% chr16 + 49019854 49019992 139 browser details YourSeq 79 357 477 1313 90.9% chr2 + 92499229 92499372 144 browser details YourSeq 76 362 481 1313 89.0% chr2 - 132699063 132699205 143 browser details YourSeq 74 310 450 1313 93.2% chr19 - 36858168 36858308 141 browser details YourSeq 73 307 477 1313 95.2% chr6 - 122506701 122507125 425 browser details YourSeq 72 362 477 1313 91.0% chr3 + 82532981 82533117 137 Note: The 1313 bp section downstream of Exon 8 is BLAT searched against the genome. No significant similarity is found. Page 5 of 9 https://www.alphaknockout.com Gene and protein information: Hnrnpa3 heterogeneous nuclear ribonucleoprotein A3 [ Mus musculus (house mouse) ] Gene ID: 229279, updated on 14-Aug-2019 Gene summary Official Symbol Hnrnpa3 provided by MGI Official Full Name heterogeneous nuclear ribonucleoprotein A3 provided by MGI Primary source MGI:MGI:1917171 See related Ensembl:ENSMUSG00000059005 Gene type protein coding RefSeq status VALIDATED Organism Mus musculus Lineage Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Also known as Hnrpa3; 2410013L13Rik; 2610209F03Rik; 2610510D13Rik Expression Broad expression in CNS E11.5 (RPKM 167.7), liver E14 (RPKM 103.2) and 15 other tissues See more Orthologs human all Genomic context Location: 2; 2 C3 See Hnrnpa3 in Genome Data Viewer Exon count: 11 Annotation release Status Assembly Chr Location 108 current GRCm38.p6 (GCF_000001635.26) 2 NC_000068.7 (75659105..75669407) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 2 NC_000068.6 (75497316..75507464) Chromosome 2 - NC_000068.7 Page 6 of 9 https://www.alphaknockout.com Transcript information: This gene has 7 transcripts Gene: Hnrnpa3 ENSMUSG00000059005 Description heterogeneous nuclear ribonucleoprotein A3 [Source:MGI Symbol;Acc:MGI:1917171] Gene Synonyms 2410013L13Rik, 2610209F03Rik, 2610510D13Rik, Hnrpa3 Location Chromosome 2: 75,659,261-75,669,407 forward strand. GRCm38:CM000995.2 About this gene This gene has 7 transcripts (splice variants), 122 orthologues, 41 paralogues and is a member of 2 Ensembl protein families. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags Hnrnpa3- ENSMUST00000111962.7 5150 357aa ENSMUSP00000107593.1 Protein coding CCDS50610 Q0VG47 TSL:1 203 Q8BG05 GENCODE basic APPRIS ALT2 Hnrnpa3- ENSMUST00000111964.7 1654 379aa ENSMUSP00000107595.1 Protein coding CCDS16149 Q5FB19 TSL:1 204 Q8BG05 GENCODE basic APPRIS P3 Hnrnpa3- ENSMUST00000090792.10 1140 379aa ENSMUSP00000088298.4 Protein coding CCDS16149 Q5FB19 TSL:5 201 Q8BG05 GENCODE basic APPRIS P3 Hnrnpa3- ENSMUST00000164947.8 1074 357aa ENSMUSP00000126069.2 Protein coding CCDS50610 Q0VG47 TSL:5 207 Q8BG05 GENCODE basic APPRIS ALT2 Hnrnpa3- ENSMUST00000111961.7 1734 318aa ENSMUSP00000107592.1 Protein coding - A2AL12 TSL:1 202 GENCODE basic APPRIS ALT2 Hnrnpa3- ENSMUST00000141974.1 754 194aa ENSMUSP00000116125.1 Protein coding - A2AL13 CDS 5' 206 incomplete TSL:2 Hnrnpa3- ENSMUST00000132392.1 596 No - Retained - - TSL:2 205 protein intron Page 7 of 9 https://www.alphaknockout.com 30.15 kb Forward strand 75.65Mb 75.66Mb 75.67Mb Genes Gm24574-201 >miRNA (Comprehensive set... Hnrnpa3-204 >protein coding Hnrnpa3-203 >protein coding Hnrnpa3-202 >protein coding Hnrnpa3-205 >retained intron Hnrnpa3-201 >protein coding Hnrnpa3-207 >protein coding Hnrnpa3-206 >protein coding Contigs AL772214.3 > AL772404.5 > Genes < Nfe2l2-201protein coding (Comprehensive set... Regulatory Build 75.65Mb 75.66Mb 75.67Mb Reverse strand 30.15 kb Regulation Legend CTCF Enhancer Open Chromatin Promoter Promoter Flank Transcription Factor Binding Site Gene Legend Protein Coding merged Ensembl/Havana Ensembl protein coding Non-Protein Coding RNA gene processed transcript Page 8 of 9 https://www.alphaknockout.com Transcript: ENSMUST00000111964 6.58 kb Forward strand Hnrnpa3-204 >protein coding ENSMUSP00000107... MobiDB lite Low complexity (Seg) Superfamily RNA-binding domain superfamily SMART RNA recognition motif domain Pfam RNA recognition motif domain PROSITE profiles RNA recognition motif domain PANTHER PTHR15241 PTHR15241:SF252 Gene3D Nucleotide-binding alpha-beta plait domain superfamily CDD hnRNP A3, RNA recognition motif 2 hnRNP A3, RNA recognition motif 1 All sequence SNPs/i... Sequence variants (dbSNP and all other sources) Variant Legend missense variant splice region variant synonymous variant Scale bar 0 40 80 120 160 200 240 280 320 379 We wish to acknowledge the following valuable scientific information resources: Ensembl, MGI, NCBI, UCSC. Page 9 of 9.
Load more

Recommended publications
  • (P -Value<0.05, Fold Change≥1.4), 4 Vs. 0 Gy Irradiation
    Table S1: Significant differentially expressed genes (P -Value<0.05, Fold Change≥1.4), 4 vs. 0 Gy irradiation Genbank Fold Change P -Value Gene Symbol Description Accession Q9F8M7_CARHY (Q9F8M7) DTDP-glucose 4,6-dehydratase (Fragment), partial (9%) 6.70 0.017399678 THC2699065 [THC2719287] 5.53 0.003379195 BC013657 BC013657 Homo sapiens cDNA clone IMAGE:4152983, partial cds. [BC013657] 5.10 0.024641735 THC2750781 Ciliary dynein heavy chain 5 (Axonemal beta dynein heavy chain 5) (HL1). 4.07 0.04353262 DNAH5 [Source:Uniprot/SWISSPROT;Acc:Q8TE73] [ENST00000382416] 3.81 0.002855909 NM_145263 SPATA18 Homo sapiens spermatogenesis associated 18 homolog (rat) (SPATA18), mRNA [NM_145263] AA418814 zw01a02.s1 Soares_NhHMPu_S1 Homo sapiens cDNA clone IMAGE:767978 3', 3.69 0.03203913 AA418814 AA418814 mRNA sequence [AA418814] AL356953 leucine-rich repeat-containing G protein-coupled receptor 6 {Homo sapiens} (exp=0; 3.63 0.0277936 THC2705989 wgp=1; cg=0), partial (4%) [THC2752981] AA484677 ne64a07.s1 NCI_CGAP_Alv1 Homo sapiens cDNA clone IMAGE:909012, mRNA 3.63 0.027098073 AA484677 AA484677 sequence [AA484677] oe06h09.s1 NCI_CGAP_Ov2 Homo sapiens cDNA clone IMAGE:1385153, mRNA sequence 3.48 0.04468495 AA837799 AA837799 [AA837799] Homo sapiens hypothetical protein LOC340109, mRNA (cDNA clone IMAGE:5578073), partial 3.27 0.031178378 BC039509 LOC643401 cds. [BC039509] Homo sapiens Fas (TNF receptor superfamily, member 6) (FAS), transcript variant 1, mRNA 3.24 0.022156298 NM_000043 FAS [NM_000043] 3.20 0.021043295 A_32_P125056 BF803942 CM2-CI0135-021100-477-g08 CI0135 Homo sapiens cDNA, mRNA sequence 3.04 0.043389246 BF803942 BF803942 [BF803942] 3.03 0.002430239 NM_015920 RPS27L Homo sapiens ribosomal protein S27-like (RPS27L), mRNA [NM_015920] Homo sapiens tumor necrosis factor receptor superfamily, member 10c, decoy without an 2.98 0.021202829 NM_003841 TNFRSF10C intracellular domain (TNFRSF10C), mRNA [NM_003841] 2.97 0.03243901 AB002384 C6orf32 Homo sapiens mRNA for KIAA0386 gene, partial cds.
    [Show full text]
  • Stroke Genetics and Genomics
    Faculdade de Medicina da Universidade de Lisboa Unidade Neurológica de Investigação Clínica PhD Thesis Stroke Genetics and Genomics Tiago Krug Coelho Host Institution: Instituto Gulbenkian de Ciência Supervisor at Instituto Gulbenkian de Ciência: Doctor Sofia Oliveira Supervisor at Faculdade de Medicina da Universidade de Lisboa: Professor José Ferro PhD in Biomedical Sciences Specialization in Neurosciences 2010 Stroke Genetics and Genomics A ciência tem, de facto, um único objectivo: a verdade. Não esgota perfeitamente a sua tarefa se não descobre a causa do todo. Chiara Lubich i Stroke Genetics and Genomics ii Stroke Genetics and Genomics A impressão desta dissertação foi aprovada pela Comissão Coordenadora do Conselho Científico da Faculdade de Medicina de Lisboa em reunião de 28 de Setembro de 2010. iii Stroke Genetics and Genomics iv Stroke Genetics and Genomics As opiniões expressas são da exclusiva responsabilidade do seu autor. v Stroke Genetics and Genomics vi Stroke Genetics and Genomics Abstract ABSTRACT This project presents a comprehensive approach to the identification of new genes that influence the risk for developing stroke. Stroke is the leading cause of death in Portugal and the third leading cause of death in the developed world. It is even more disabling than lethal, and the persistent neurological impairment and physical disability caused by stroke have a very high socioeconomic cost. Moreover, the number of affected individuals is expected to increase with the current aging of the population. Stroke is a “brain attack” cutting off vital blood and oxygen to the brain cells and it is a complex disease resulting from environmental and genetic factors.
    [Show full text]
  • The Role of Hnrnps in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis
    Acta Neuropathologica https://doi.org/10.1007/s00401-020-02203-0 REVIEW The role of hnRNPs in frontotemporal dementia and amyotrophic lateral sclerosis Alexander Bampton1,2 · Lauren M. Gittings3 · Pietro Fratta4 · Tammaryn Lashley1,2 · Ariana Gatt1,2 Received: 25 June 2020 / Revised: 27 July 2020 / Accepted: 27 July 2020 © The Author(s) 2020 Abstract Dysregulated RNA metabolism is emerging as a crucially important mechanism underpinning the pathogenesis of fron- totemporal dementia (FTD) and the clinically, genetically and pathologically overlapping disorder of amyotrophic lateral sclerosis (ALS). Heterogeneous nuclear ribonucleoproteins (hnRNPs) comprise a family of RNA-binding proteins with diverse, multi-functional roles across all aspects of mRNA processing. The role of these proteins in neurodegeneration is far from understood. Here, we review some of the unifying mechanisms by which hnRNPs have been directly or indirectly linked with FTD/ALS pathogenesis, including their incorporation into pathological inclusions and their best-known roles in pre-mRNA splicing regulation. We also discuss the broader functionalities of hnRNPs including their roles in cryptic exon repression, stress granule assembly and in co-ordinating the DNA damage response, which are all emerging patho- genic themes in both diseases. We then present an integrated model that depicts how a broad-ranging network of pathogenic events can arise from declining levels of functional hnRNPs that are inadequately compensated for by autoregulatory means. Finally, we provide a comprehensive overview of the most functionally relevant cellular roles, in the context of FTD/ALS pathogenesis, for hnRNPs A1-U. Keywords hnRNP · Frontotemporal dementia · Amyotrophic lateral sclerosis · RNA · Autoregulation Introduction RNA and protein homeostasis have been identifed as con- verging mechanisms of neurotoxicity in both disorders.
    [Show full text]
  • Genetically Modified Macrophages and Renal Regeneration
    Genetically Modified Macrophages and Renal Regeneration Chrysoula Mastora ADVERTIMENT. La consulta d’aquesta tesi queda condicionada a l’acceptació de les següents condicions d'ús: La difusió d’aquesta tesi per mitjà del servei TDX (www.tdx.cat) i a través del Dipòsit Digital de la UB (diposit.ub.edu) ha estat autoritzada pels titulars dels drets de propietat intel·lectual únicament per a usos privats emmarcats en activitats d’investigació i docència. No s’autoritza la seva reproducció amb finalitats de lucre ni la seva difusió i posada a disposició des d’un lloc aliè al servei TDX ni al Dipòsit Digital de la UB. No s’autoritza la presentació del seu contingut en una finestra o marc aliè a TDX o al Dipòsit Digital de la UB (framing). Aquesta reserva de drets afecta tant al resum de presentació de la tesi com als seus continguts. En la utilització o cita de parts de la tesi és obligat indicar el nom de la persona autora. ADVERTENCIA. La consulta de esta tesis queda condicionada a la aceptación de las siguientes condiciones de uso: La difusión de esta tesis por medio del servicio TDR (www.tdx.cat) y a través del Repositorio Digital de la UB (diposit.ub.edu) ha sido autorizada por los titulares de los derechos de propiedad intelectual únicamente para usos privados enmarcados en actividades de investigación y docencia. No se autoriza su reproducción con finalidades de lucro ni su difusión y puesta a disposición desde un sitio ajeno al servicio TDR o al Repositorio Digital de la UB.
    [Show full text]
  • Supplementary Table 1 Genes Tested in Qrt-PCR in Nfpas
    Supplementary Table 1 Genes tested in qRT-PCR in NFPAs Gene Bank accession Gene Description number ABI assay ID a disintegrin-like and metalloprotease with thrombospondin type 1 motif 7 ADAMTS7 NM_014272.3 Hs00276223_m1 Rho guanine nucleotide exchange factor (GEF) 3 ARHGEF3 NM_019555.1 Hs00219609_m1 BCL2-associated X protein BAX NM_004324 House design Bcl-2 binding component 3 BBC3 NM_014417.2 Hs00248075_m1 B-cell CLL/lymphoma 2 BCL2 NM_000633 House design Bone morphogenetic protein 7 BMP7 NM_001719.1 Hs00233476_m1 CCAAT/enhancer binding protein (C/EBP), alpha CEBPA NM_004364.2 Hs00269972_s1 coxsackie virus and adenovirus receptor CXADR NM_001338.3 Hs00154661_m1 Homo sapiens Dicer1, Dcr-1 homolog (Drosophila) (DICER1) DICER1 NM_177438.1 Hs00229023_m1 Homo sapiens dystonin DST NM_015548.2 Hs00156137_m1 fms-related tyrosine kinase 3 FLT3 NM_004119.1 Hs00174690_m1 glutamate receptor, ionotropic, N-methyl D-aspartate 1 GRIN1 NM_000832.4 Hs00609557_m1 high-mobility group box 1 HMGB1 NM_002128.3 Hs01923466_g1 heterogeneous nuclear ribonucleoprotein U HNRPU NM_004501.3 Hs00244919_m1 insulin-like growth factor binding protein 5 IGFBP5 NM_000599.2 Hs00181213_m1 latent transforming growth factor beta binding protein 4 LTBP4 NM_001042544.1 Hs00186025_m1 microtubule-associated protein 1 light chain 3 beta MAP1LC3B NM_022818.3 Hs00797944_s1 matrix metallopeptidase 17 MMP17 NM_016155.4 Hs01108847_m1 myosin VA MYO5A NM_000259.1 Hs00165309_m1 Homo sapiens nuclear factor (erythroid-derived 2)-like 1 NFE2L1 NM_003204.1 Hs00231457_m1 oxoglutarate (alpha-ketoglutarate)
    [Show full text]
  • Highly Conserved Syntenic Blocks at the Vertebrate Hox Loci and Conserved Regulatory Elements Within and Outside Hox Gene Clusters
    Highly conserved syntenic blocks at the vertebrate Hox loci and conserved regulatory elements within and outside Hox gene clusters Alison P. Lee, Esther G. L. Koh, Alice Tay, Sydney Brenner†, and Byrappa Venkatesh† Institute of Molecular and Cell Biology, 61 Biopolis Drive, Singapore 138673 Contributed by Sydney Brenner, February 22, 2006 Hox genes in vertebrates are clustered, and the organization of the Another factor that may have contributed to the clustering and clusters has been highly conserved during evolution. The conser- colinearity of Hox genes is the existence of global enhancers that vation of Hox clusters has been attributed to enhancers located regulate several genes in a manner independent of their local within and outside the Hox clusters that are essential for the enhancers but dependent on their location in the cluster. Global coordinated ‘‘temporal’’ and ‘‘spatial’’ expression patterns of Hox control regions (GCRs) have been identified on either side of the genes in developing embryos. To identify evolutionarily conserved HoxD cluster. The 5Ј HoxD GCR, regulating the expression of regulatory elements within and outside the Hox clusters, we Lnp, Evx2, and posterior HoxD genes in developing digits and the obtained contiguous sequences for the conserved syntenic blocks central nervous system, is located Ϸ240 kb upstream of HoxD13 from the seven Hox loci in fugu and carried out a systematic search in the intergenic region between Atp5g3 and Lnp (3). The 3Ј for conserved noncoding sequences (CNS) in the human, mouse, HoxD GCR mapped downstream of HoxD1, called early limb and fugu Hox loci. Our analysis has uncovered unusually large control region, is implicated in the early colinear expression of conserved syntenic blocks at the HoxA and HoxD loci.
    [Show full text]
  • Host Cell Factors Necessary for Influenza a Infection: Meta-Analysis of Genome Wide Studies
    Host Cell Factors Necessary for Influenza A Infection: Meta-Analysis of Genome Wide Studies Juliana S. Capitanio and Richard W. Wozniak Department of Cell Biology, Faculty of Medicine and Dentistry, University of Alberta Abstract: The Influenza A virus belongs to the Orthomyxoviridae family. Influenza virus infection occurs yearly in all countries of the world. It usually kills between 250,000 and 500,000 people and causes severe illness in millions more. Over the last century alone we have seen 3 global influenza pandemics. The great human and financial cost of this disease has made it the second most studied virus today, behind HIV. Recently, several genome-wide RNA interference studies have focused on identifying host molecules that participate in Influen- za infection. We used nine of these studies for this meta-analysis. Even though the overlap among genes identified in multiple screens was small, network analysis indicates that similar protein complexes and biological functions of the host were present. As a result, several host gene complexes important for the Influenza virus life cycle were identified. The biological function and the relevance of each identified protein complex in the Influenza virus life cycle is further detailed in this paper. Background and PA bound to the viral genome via nucleoprotein (NP). The viral core is enveloped by a lipid membrane derived from Influenza virus the host cell. The viral protein M1 underlies the membrane and anchors NEP/NS2. Hemagglutinin (HA), neuraminidase Viruses are the simplest life form on earth. They parasite host (NA), and M2 proteins are inserted into the envelope, facing organisms and subvert the host cellular machinery for differ- the viral exterior.
    [Show full text]
  • Comparative Gene Expression Analysis of Blood and Brain Provides Concurrent Validation of SELENBP1 Up-Regulation in Schizophrenia
    Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia Stephen J. Glatta,b,c,d, Ian P. Everallb,c,e, William S. Kremena,c, Jacques Corbeilf,g, Roman Saˇ ´ sˇikh, Negar Khanlouc,e, Mark Hani, Choong-Chin Liewi, and Ming T. Tsuanga,c,j,k,l aCenter for Behavioral Genomics, Departments of cPsychiatry and gMedicine, hUniversity of California San Diego Cancer Center, and eHIV Neurobehavioral Research Center, University of California at San Diego, La Jolla, CA 92093; dVeterans Medical Research Foundation, San Diego, CA 92161; fDepartment of Anatomy and Physiology, Laval University, Quebec, PQ, Canada G1V 4G2; iChondroGene, Inc., Toronto, ON, Canada M3J 3K4; jDepartments of Epidemiology and Psychiatry, Harvard Institute of Psychiatric Epidemiology and Genetics, Boston, MA 02115; and kVeterans Affairs Healthcare System, San Diego, CA 92161 Communicated by Eric R. Kandel, Columbia University, New York, NY, September 1, 2005 (received for review July 28, 2005) Microarray techniques hold great promise for identifying risk come under study. Because gene expression can reflect both genetic factors for schizophrenia (SZ) but have not yet generated widely and environmental influences, it may be particularly useful for reproducible results due to methodological differences between identifying risk factors for a complex disorder such as SZ, which is studies and the high risk of type I inferential errors. Here we thought to have a multifactorial polygenic etiology in which many established a protocol for conservative analysis and interpretation genes and environmental factors interact. However, the simulta- of gene expression data from the dorsolateral prefrontal cortex of neous consideration of thousands of dependent variables also SZ patients using statistical and bioinformatic methods that limit increases the likelihood of false-positive results (7).
    [Show full text]
  • Oligonucleotide Microarray Analysis of Distinct Gene Expression Patterns in Colorectal Cancer Tissues Harboring BRAF and K-Ras Mutations
    Carcinogenesis vol.27 no.3 pp.392–404, 2006 doi:10.1093/carcin/bgi237 Advance Access publication October 11, 2005 Oligonucleotide microarray analysis of distinct gene expression patterns in colorectal cancer tissues harboring BRAF and K-ras mutations Il-Jin Kim1,y, Hio Chung Kang1,2,y, Sang-Geun Jang1, Introduction Kun Kim1, Sun-A Ahn1, Hyun-Ju Yoon1, Sang Nam Yoon3 and Jae-Gahb Park1,2,3,Ã Colorectal cancer (CRC) is an important human cancer, and incidence rates of this cancer are increasing in Asian countries 1 Korean Hereditary Tumor Registry, Cancer Research Institute and such as Korea (1). CRC development is a multi-step process Downloaded from https://academic.oup.com/carcin/article/27/3/392/2476120 by guest on 27 September 2021 Cancer Research Center, Seoul National University, Seoul, Korea, (2) involving microsatellite instability (MSI), mutations in 2Research Institute and Hospital, National Cancer Center, 809 Madu-dong, Ilsan-gu, Goyang, Gyeonggi 411-764, Korea mismatch repair (MMR) of genes such as MLH1 and MSH2, and 3Department of Surgery, Seoul National University College of and mutations in APC, SMAD4,K-ras, TP53 and b-catenin Medicine, Seoul, Korea (2–9). Somatic BRAF mutations have been reported in ÃTo whom correspondence should be addressed. 5.1–18% of CRCs (10–12). BRAF is one of three serine/ E-mail: [email protected] threonine kinases (ARAF, BRAF, CRAF/RAF1) that act within Various types of human cancers harbor BRAF somatic the RAS–RAF–MEK–ERK–MAPK signaling pathway (13). mutations, leading researchers to seek molecular targets BRAF mutations have also been reported in 80% of primary for BRAF inhibitors.
    [Show full text]
  • 393LN V 393P 344SQ V 393P Probe Set Entrez Gene
    393LN v 393P 344SQ v 393P Entrez fold fold probe set Gene Gene Symbol Gene cluster Gene Title p-value change p-value change chemokine (C-C motif) ligand 21b /// chemokine (C-C motif) ligand 21a /// chemokine (C-C motif) ligand 21c 1419426_s_at 18829 /// Ccl21b /// Ccl2 1 - up 393 LN only (leucine) 0.0047 9.199837 0.45212 6.847887 nuclear factor of activated T-cells, cytoplasmic, calcineurin- 1447085_s_at 18018 Nfatc1 1 - up 393 LN only dependent 1 0.009048 12.065 0.13718 4.81 RIKEN cDNA 1453647_at 78668 9530059J11Rik1 - up 393 LN only 9530059J11 gene 0.002208 5.482897 0.27642 3.45171 transient receptor potential cation channel, subfamily 1457164_at 277328 Trpa1 1 - up 393 LN only A, member 1 0.000111 9.180344 0.01771 3.048114 regulating synaptic membrane 1422809_at 116838 Rims2 1 - up 393 LN only exocytosis 2 0.001891 8.560424 0.13159 2.980501 glial cell line derived neurotrophic factor family receptor alpha 1433716_x_at 14586 Gfra2 1 - up 393 LN only 2 0.006868 30.88736 0.01066 2.811211 1446936_at --- --- 1 - up 393 LN only --- 0.007695 6.373955 0.11733 2.480287 zinc finger protein 1438742_at 320683 Zfp629 1 - up 393 LN only 629 0.002644 5.231855 0.38124 2.377016 phospholipase A2, 1426019_at 18786 Plaa 1 - up 393 LN only activating protein 0.008657 6.2364 0.12336 2.262117 1445314_at 14009 Etv1 1 - up 393 LN only ets variant gene 1 0.007224 3.643646 0.36434 2.01989 ciliary rootlet coiled- 1427338_at 230872 Crocc 1 - up 393 LN only coil, rootletin 0.002482 7.783242 0.49977 1.794171 expressed sequence 1436585_at 99463 BB182297 1 - up 393
    [Show full text]
  • Cervix Cancer
    Microarrays 2015, 4, 287-310; doi:10.3390/microarrays4020287 OPEN ACCESS microarrays ISSN 2076-3905 www.mdpi.com/journal/microarrays Article An Optimization-Driven Analysis Pipeline to Uncover Biomarkers and Signaling Paths: Cervix Cancer Enery Lorenzo 1, Katia Camacho-Caceres 1, Alexander J. Ropelewski 2, Juan Rosas 1, Michael Ortiz-Mojer 1, Lynn Perez-Marty 1, Juan Irizarry 1, Valerie Gonzalez 1, Jesús A. Rodríguez 1, Mauricio Cabrera-Rios 1 and Clara Isaza 1,3,* 1 Bio IE Lab, The Applied Optimization Group at UPRM, Industrial Engineering Department, University of Puerto Rico at Mayaguez, Call Box 9000, Mayagüez, PR 00681, USA; E-Mails: [email protected] (E.L.); [email protected] (K.C.-C.); [email protected] (J.R.); [email protected] (M.O.-M.); [email protected] (J.I.); [email protected] (V.G.); [email protected] (J.A.R.); [email protected] (M.C.-R.) 2 Pittsburgh Supercomputing Center, 300 S. Craig Street, Pittsburgh, PA 15213, USA; E-Mail: [email protected] 3 Department of Pharmacology and Toxicology, Ponce School of Medicine, PO Box 700, Ponce, PR 00732, USA * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-787-840-2575 (ext. 2198). Academic Editor: Shu-Kay Ng Received: 22 February 2015 / Accepted: 13 May 2015 / Published: 28 May 2015 Abstract: Establishing how a series of potentially important genes might relate to each other is relevant to understand the origin and evolution of illnesses, such as cancer. High-throughput biological experiments have played a critical role in providing information in this regard.
    [Show full text]
  • Transcriptome Characterization of Human Mammary Cell Lines Expressing Different Levels of ERBB2 by Serial Analysis of Gene Expression
    1441-1461 26/4/06 13:24 Page 1441 INTERNATIONAL JOURNAL OF ONCOLOGY 28: 1441-1461, 2006 Transcriptome characterization of human mammary cell lines expressing different levels of ERBB2 by serial analysis of gene expression MARIANA LOPES DOS SANTOS1, CAROLINA GONÇALVES PALANCH1, SIBELI SALAORNI1, WILSON ARAUJO DA SILVA Jr2 and MARIA APARECIDA NAGAI1 1Disciplina de Oncologia, Departamento de Radiologia da Faculdade de Medicina da Universidade de São Paulo, São Paulo; 2Departamento de Genética, Faculdade de Medicina de Ribeirão Preto-USP, Ribeirão Preto, Brazil Received October 31, 2005; Accepted December 27, 2005 Abstract. Over-expression of ERBB2, a member of the family Introduction of transmembrane receptor tyrosine kinases, occurs in 15-30% of primary breast tumors and is associated with poor prognosis The ERBB2 gene, also known as HER2/NEU, encodes a and chemoresistance to a variety of anticancer drugs. In this 185-kDa transmembrane glycoprotein with intrinsic tyrosine study, aiming to identify differentially-expressed genes kinase activity that belongs to the epidermal growth factor involved in erbB2-mediated transformation of the breast, we receptor (EGFR) family (1). This family of receptor tyrosine generated SAGE libraries from two human mammary cell kinases (RTKs) comprises four members, EGFR (ERBB1), lines, derived from normal luminal cells, expressing different ERBB2 (HER2), ERBB3 and ERBB4 that play important roles levels of erbB2. The parental cell line HB4a expresses basal in several signal transduction pathways regulating cell prolifer- levels and the C5.2 expresses high levels of erbB2. A total of ation, differentiation, cytoskeletal rearrangement and survival 161,632 tags was generated by sequencing, 81,684 from HB4a (1,2).
    [Show full text]